Ranbaxy Laboratories, Inc.

Sun Pharmaceutical Industries Limited

Santosh Richhariya

Kaptan Singh

Hashim Nizar Poovanathil Nagoor Meeran

Satish Manohar Bhoge

Prakash Kshirsagar

Mohan Prasad

Neera Tewari

Prasenjit Prafulla Das

Vishwesh Pravinchandra Pandya

Prabhakar Divya

Prakash Bhimaji Kshirsagar

The present disclosure provides a process for the preparation of ixazomib citrate.

Process for the preparation of ixazomib citrate

The present invention relates to process for the preparation of fosamprenavir calcium.

Process for the preparation of fosamprenavir calcium

The present invention provides an improved process for stereoselective preparation of 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine and pharmaceutically acceptable salts thereof.

Process for stereoselective synthesis of 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

The present invention provides a process for preparing novel intermediates of Formula wherein, Rcan be hydrogen, C-Calkyl, halogen, nitro, hydroxy, or C-Calkoxy; Rcan be selected from hydrophobic residue of HMG-CoA reductase inhibitors; which can be effectively used for the preparation of HMG-CoA reductase inhibitors such as rosuvastatin and pharmaceutically acceptable salts thereof. 

Intermediates for the preparation of HMG-CoA reductase inhibitors

Growing community of inventors

Sagar, India

Santosh Richhariya